source
- Gene therapy viral vectors implicated in a child’s tumor, raising safety concernsA recent STAT+ report highlights a case where viral vectors used in gene therapy were found to be associated with a tumor in a young boy. The article notes that investigators have identified a poss…
- Tessera Therapeutics reports infusion gene edit corrects 85% of blood cells in sickle cell studyTessera Therapeutics announced new data from its in-vivo gene editing program targeting sickle cell disease. The experimental therapy is given as a simple infusion, avoiding the complex cell engin…